白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00874 白云山

未开盘 10-22 16:08:35

12.800

-0.220

-1.69%

最高13.010	最低12.770	成交量137.00万
今开13.010	昨收13.020	日振幅1.84%
总市值208.13亿	流通市值28.15亿	总股本16.26亿
成交额1,758万	换手率0.62%	流通股本2.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":12.8,"timestamp":1792656515002,"preClose":13.02,"halted":0,"volume":1370000,"delay":0,"changeRate":-0.01689708141321036,"floatShares":219900000,"shares":1626000000,"eps":1.835,"marketStatus":"未开盘","change":-0.22,"latestTime":"10-22 16:08:35","open":13.01,"high":13.01,"low":12.77,"amount":17581380,"amplitude":0.018433,"askPrice":12.8,"askSize":4000,"bidPrice":12.77,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":1.819705,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792719000000},"marketStatusCode":0,"adr":0,"listingDate":878140800000,"exchange":"SEHK","adjPreClose":13.02,"dividendRate":0.067422,"openAndCloseTimeList":[[1792632600000,1792641600000],[1792645200000,1792656000000]],"volumeRatio":1.3716185097180216,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":19.51,"timestamp":1792652400000,"preClose":19.73,"halted":0,"volume":6182600,"delay":0,"premium":"-44.14"}},"requestUrl":"/m/hq/s/00874","defaultTab":"news","newsList":[{"id":"2677648853","title":"白云山（600332）10月20日主力资金净卖出559.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677648853","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677648853?lang=zh_cn&edition=full","pubTime":"2026-10-21 08:31","pubTimestamp":1792542707,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月20日收盘，白云山报收于19.84元，下跌2.12%，换手率0.76%，成交量10.72万手，成交额2.14亿元。10月20日的资金流向数据方面，主力资金净流出559.59万元，占总成交额2.62%，游资资金净流入1214.01万元，占总成交额5.69%，散户资金净流出654.42万元，占总成交额3.07%。近5日资金流向一览见下表：白云山融资融券信息显示，融资方面，当日融资买入2362.09万元，融资偿还1962.7万元，融资净买入399.39万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100007258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1521","BK0175","BK0070","BK0097","BK1606","00874","BK0196","600332","BK0188","BK0012","BK1191","BK1197","BK1515","BK0096","BK0028","BK0239","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676652427","title":"广药白云山海创（海南）科技有限公司成立，注册资本3000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676652427","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676652427?lang=zh_cn&edition=full","pubTime":"2026-10-20 14:05","pubTimestamp":1792476338,"startTime":"0","endTime":"0","summary":"天眼查App显示，近日，广药白云山海创（海南）科技有限公司成立，法定代表人为赵全，注册资本3000万元人民币，经营范围包括第一类医疗器械销售、健康咨询服务、会议及展览服务等。股东信息显示，该公司由广州白云山医药集团股份有限公司、海口国家高新区国际投资发展有限公司分别持股90%、10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610203901247158.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610203901247158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","BK1515","BK0012","BK0196","BK0175","BK1606","BK0070","600332","00874","BK0239","BK1197","BK1521","BK0097","BK0183","BK0096","BK1191","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675139551","title":"港股公告掘金 | 云迹前九个月机器人运营规模保持稳健增长 产品累计覆盖超过4.5万家酒店","url":"https://stock-news.laohu8.com/highlight/detail?id=2675139551","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675139551?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:59","pubTimestamp":1792112382,"startTime":"0","endTime":"0","summary":"【重大事项】谊砾控股(00076)拟最高7.54亿港元收购AOMI Corporation 69%股权腾盛博药-B(02137)宣布推出BRiSC siRNA药物研发平台石药集团(01093)：SYS 6088注射液(三特异性抗体)在中国获临床试验批准白云山(00874)：硫酸阿米卡星注射液(2ml:0.2g)(20万单位)已通过仿制药质量和疗效一致性评价讯飞医疗科技(02506)与上海瑞慈医疗订","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1508095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02670","LU1226288170.HKD","LU0067412154.USD","LU1152091754.HKD","ROBO","KCAI","02915","LU0315179316.USD","LU1226287529.USD","LU1008478684.HKD","PBOT","LU0140636845.USD","LU1951186391.HKD","LU1152091168.USD","BK1606","BK1183","LU0880133367.SGD","LU2039709279.SGD","00076","LU1807302812.USD","KURE","LU0314109678.HKD","IE00BZ08YR35.GBP","HK0000165453.HKD","LU1328277881.USD","PEJ","SG9999004220.SGD","IE00BZ08YT58.USD","BK1167","BK4585","IE0008368742.USD","KOMP","02137","LU1226287792.SGD","LU1813983027.USD","LU1960683339.HKD","VXUS","BK1147","BK1161","LU0501845795.SGD","BK1521","IE0008369823.USD","BK1574","BK4588","LU1993786604.SGD","LU1226287875.USD","IE00BZ08YS42.EUR","01093","00874","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675455167","title":"【券商聚焦】中信证券：市场风格趋于谨慎 中药高股息标的关注度持续上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2675455167","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675455167?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:52","pubTimestamp":1792111979,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券表示，近期，市场风格趋于谨慎，中药高股息标的关注度持续上升。在此背景下，中药板块凭借\"低估值+高股息+成本端改善\"三重属性，成为具备高确定性的细分投资板块。该机构梳理两条投资主线：1）高股息率、业绩稳健标的。2）业绩边际向好、股息率具备一定吸引力的标的。风险因素：渠道库存积压的风险；业绩不及预期的风险；成本上涨的风险；集采不及预期的风险；重大支出后降低股息率的风险。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993818","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","02161","LU1781817850.SGD","QUSA","02877","PY","BK0012","BK1570","BK1147","BK0188","LU1820825898.SGD","BK0276","BK0183","PRIZ","159207","KCE","600030","LU2580892789.USD","LU1794554557.SGD","BK1515","LU1255011170.USD","LU2580892862.HKD","LU0405327494.USD","LU1064130708.USD","LU1064131003.USD","00570","00874","03613","ABEQ","BK1191","02273","LU1146622755.USD","01643","LU0405327148.USD","BK1521","LU1997244956.HKD","BK0196","LU2148510915.USD","BK1516","LU1328615791.USD","06030","BK1197","CGVV","LU2289578879.USD","BK1564","LU1580142542.USD","EASY","FTDS","LU1720050803.USD","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675452304","title":"白云山(600332.SH)子公司硫酸阿米卡星注射液通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2675452304","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675452304?lang=zh_cn&edition=full","pubTime":"2026-10-15 16:16","pubTimestamp":1792052204,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山 发布公告，近日，公司控股子公司广州白云山天心制药股份有限公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，硫酸阿米卡星注射液已通过仿制药质量和疗效一致性评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","00874","BK0097","BK1521","BK1606","BK0196","BK0183","BK1191","BK0070","BK0028","BK0239","BK1197","BK1515","BK0012","BK0096","BK0175","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675375677","title":"白云山（600332）10月14日主力资金净卖出2376.92万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675375677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675375677?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:23","pubTimestamp":1792023826,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，白云山报收于20.06元，上涨0.91%，换手率0.5%，成交量7.08万手，成交额1.42亿元。10月14日的资金流向数据方面，主力资金净流出2376.92万元，占总成交额16.76%，游资资金净流入986.74万元，占总成交额6.96%，散户资金净流入1390.19万元，占总成交额9.8%。近5日资金流向一览见下表：白云山融资融券信息显示，融资方面，当日融资买入869.46万元，融资偿还1445.74万元，融资净偿还576.28万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500006979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0070","BK1191","BK0096","600332","BK0196","BK0097","BK0175","BK0188","BK1197","BK1521","BK1606","BK1515","00874","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362811","title":"股市必读：白云山新发布《广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362811","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675362811?lang=zh_cn&edition=full","pubTime":"2026-10-14 03:55","pubTimestamp":1791921310,"startTime":"0","endTime":"0","summary":"公司公告汇总广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通知书的公告广州白云山医药集团股份有限公司子公司广州白云山陈李济药厂有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意舒筋健腰丸开展用于腰椎间盘突出症肝肾不足、风湿瘀阻证的临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400003744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1606","BK1197","BK0028","BK0096","BK0175","BK0239","600332","09939","BK0196","BK0188","BK0012","BK0097","BK0070","159938","BK1521","BK1161","BK1515","BK1191","BK0183","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675305633","title":"白云山（600332）披露子公司获得舒筋健腰丸新增适应症临床试验批准通知书，10月13日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675305633","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675305633?lang=zh_cn&edition=full","pubTime":"2026-10-13 17:34","pubTimestamp":1791884077,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，白云山报收于19.88元，较前一交易日下跌1.0%，最新总市值为323.21亿元。广州白云山医药集团股份有限公司于近日披露《关于子公司获得药物临床试验批准通知书的公告》。公告显示，公司子公司广州白云山陈李济药厂有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意舒筋健腰丸开展用于腰椎间盘突出症肝肾不足、风湿瘀阻证的临床试验。舒筋健腰丸为已上市中药复方制剂，本次申请新增功能主治。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300029557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0028","BK1521","BK0183","BK1606","600332","BK0097","BK0188","BK0239","BK0096","BK0070","BK1515","BK1197","BK0196","BK0012","BK0175","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172694498","title":"白云山（00874）拟于10月28日审议截至9月30日九个月未经审计业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1172694498","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172694498?lang=zh_cn&edition=full","pubTime":"2026-10-13 16:35","pubTimestamp":1791880555,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司（00874）10月13日公告称，董事会已决定于2026年10月28日（星期三）召开会议，审议并批准公司及其附属公司截至2026年9月30日止九个月的未经审计财务业绩，并处理其他相关事项（如有）。截至公告日，董事会成员包括执行董事陈杰辉、袁诚、程洪进、唐和平、刘漤、刘宏；非执行董事黄纪元；以及独立非执行董事黄龙德、孙宝清、吴向能、杨印宝。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674769548","title":"白云山（600332）披露股权投资基金完成管理人变更备案暨关联交易进展公告，10月12日股价上涨0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674769548","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674769548?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:52","pubTimestamp":1791798733,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，白云山报收于20.08元，较前一交易日上涨0.55%，最新总市值为326.46亿元。该股当日开盘20.0元，最高20.15元，最低19.96元，成交额达1.37亿元，换手率为0.49%。近日，广州白云山医药集团股份有限公司发布《关于股权投资基金完成管理人变更备案暨关联交易进展公告》。公司认缴出资4,600万元，占基金总规模的40%。公告同时提示，基金运作存在投资风险，公司将持续关注进展并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200024261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0070","BK0183","BK0239","BK1191","BK1521","BK0196","600332","BK0175","BK1606","BK1197","BK0012","00874","BK1515","BK0097","BK0028","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674820619","title":"白云山(600332.SH)子公司舒筋健腰丸获批临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2674820619","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674820619?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:11","pubTimestamp":1791792684,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(600332.SH)发布公告，近日，公司子公司广州白云山陈李济药厂有限公司(简称“陈李济药厂”)收到国家药品监督管理局核准签发的关于舒筋健腰丸新增功能主治的《药物临床试验批准通知书》。同意本品开展用于腰椎间盘突出症肝肾不足、风湿瘀阻证的临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK1191","IBBQ","BK0188","PSYK","BK0196","00874","BK0012","BK1521","BK0239","BK0097","BK0070","BK0096","BK1197","BMED","600332","IBBJ","BK0175","BK1606","BK1515","MDTX","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674084610","title":"股市必读：白云山新发布《H股公告（证券变动月报表）》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674084610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674084610?lang=zh_cn&edition=full","pubTime":"2026-10-12 03:53","pubTimestamp":1791748389,"startTime":"0","endTime":"0","summary":"公司公告汇总H股公告截至2026年9月30日，公司H股与A股的法定/注册股本、已发行股份及库存股份数目均无变动。广州白云山医药集团股份有限公司关于子公司收到药品注册证书的公告控股子公司广州白云山天心制药股份有限公司收到国家药监局核准签发的厄贝沙坦氢氯噻嗪片《药品注册证书》，用于治疗原发性高血压，注册分类为化学药品4类，批准文号有效期至2031年9月28日；研发费用投入约1,291.53万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200001242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["00874","BK0239","BK0070","BK0183","BK0012","BK0175","BK1515","BK0196","BK0096","BK1606","600332","BK1521","161027","BK0097","BK1191","BK1197","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674858710","title":"白云山（600332）披露截至2026年9月30日证券变动月报表，10月9日股价上涨1.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674858710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674858710?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:59","pubTimestamp":1791539993,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，白云山报收于19.97元，较前一交易日上涨1.42%，最新总市值为324.67亿元。该股当日开盘19.69元，最高20.04元，最低19.69元，成交额达2.21亿元，换手率为0.79%。公司于近日披露《证券变动月报表》，显示截至2026年9月30日，广州白云山医药集团股份有限公司H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股于香港联交所上市，证券代码00874；A股于上交所上市，证券代码600332。本月底注册股本总额为人民币1,625,790,949元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900028556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0012","BK1606","BK0070","BK0097","BK0188","BK1191","BK1521","BK0096","BK1515","BK0028","600332","BK0183","BK0175","161027","BK0239","00874","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103013022","title":"白云山(00874)子公司获批厄贝沙坦氢氯噻嗪片注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=1103013022","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103013022?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:55","pubTimestamp":1791539747,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司10月9日公告称，其控股子公司广州白云山天心制药股份有限公司已收到国家药品监督管理局核准签发的厄贝沙坦氢氯噻嗪片《药品注册证书》。该复方制剂适用于单用厄贝沙坦或氢氯噻嗪无法有效控制血压的原发性高血压患者。米内网数据显示，2025年厄贝沙坦氢氯噻嗪片在国内城市、县级公立医院及城市网上药店销售额为160,815万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132076465","title":"白云山（00874）旗下广药金藏基金完成管理人变更备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1132076465","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132076465?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:55","pubTimestamp":1791539733,"startTime":"0","endTime":"0","summary":"2026年10月9日，广州白云山医药集团股份有限公司发布公告称，其参投的广州广药金藏股权投资合伙企业已于2026年9月30日在中国证券投资基金业协会完成基金管理人变更备案，并重新取得《私募投资基金备案证明》。自即日起，基金管理人由广东广药金申股权投资基金管理有限公司变更为广州广药资本私募基金管理有限公司，托管人仍为中国光大银行股份有限公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674586848","title":"白云山最新公告：收到厄贝沙坦氢氯噻嗪片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2674586848","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674586848?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:50","pubTimestamp":1791539421,"startTime":"0","endTime":"0","summary":"白云山(600332.SH)公告称，控股子公司广州白云山天心制药股份有限公司（简称“天心制药”）收到国家药品监督管理局核准签发的关于厄贝沙坦氢氯噻嗪片的《药品注册证书》。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900028196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0175","00874","BK0239","BK0196","BK0188","600332","BK0183","BK1521","BK0012","BK1515","BK1606","BK0070","BK0097","BK1197","BK0028","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674397004","title":"股市必读：白云山新发布《H股公告（证券变动月报表）》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674397004","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674397004?lang=zh_cn&edition=full","pubTime":"2026-10-09 01:42","pubTimestamp":1791481332,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，白云山报收于19.69元，下跌0.15%，换手率0.4%，成交量5.68万手，成交额1.12亿元。公司公告汇总：白云山提交截至2026年9月30日的H股证券变动月报表，H股与A股法定/注册股本、已发行股份及库存股份数目均无变动。H股于香港联交所上市，证券代码00874；A股于上交所上市，证券代码600332。公司确认已符合香港联交所规定的公众持股量要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900001870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0012","BK0070","BK0175","BK1191","BK0028","BK1197","BK1515","BK0239","161027","BK1521","00874","BK0183","600332","BK0188","BK1606","BK0097","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673044541","title":"中医药板块普涨 绿叶制药（02186）涨2.23%  机构指板块有望迎估值与业绩双重修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044541","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673044541?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:45","pubTimestamp":1791423956,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股中医药板块盘初普涨，截至发稿，中国中药 涨4.98%，吉林长龙药业涨3.23%，绿叶制药涨2.23%，白云山涨1.84%，神威药业涨1.42%，华润医药涨1.05%。随着基药目录红利的Q4落地、库存周期的边际改善以及成本红利的持续释放，板块有望迎来估值与业绩的双重修复。OTC板块核心变量是成本下行和渠道去库，Q4呼吸系统疾病发病率若季节性回升，感冒呼吸类OTC终端动销有望回暖；消费中药若消费环境边际回暖，品牌中药的收入端弹性较大。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993277","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","03320","BK1570","BK1606","02186","00874","02877","BK1583","00570","08049","BK1197","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189422964","title":"白云山9月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1189422964","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189422964?lang=zh_cn&edition=full","pubTime":"2026-10-02 16:37","pubTimestamp":1790930243,"startTime":"0","endTime":"0","summary":"2026年10月2日，广州白云山医药集团股份有限公司发布截至2026年9月30日的证券变动月报表。公告显示，报告期内公司已发行股份总数及注册股本均保持稳定，未发生新增发行、购回或注销等变动。公司无任何库藏股份，H股与A股的发行及持股量均与上月末一致。白云山在公告中简要声明，所有发行活动均符合香港联交所《上市规则》及相关法律规定，并再次确认当月无新增股份发行或回购行为。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671254538","title":"股市必读：白云山（600332）9月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2671254538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671254538?lang=zh_cn&edition=full","pubTime":"2026-09-29 01:31","pubTimestamp":1790616671,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，白云山报收于19.45元，上涨0.31%，换手率0.32%，成交量4.55万手，成交额8838.18万元。股价持续下跌表明市场不认同公司传递的公司价值。公司披露的最新股东户数是截至2026年6月30日的户数，股东数为110,167户。该产品是公司持股比例为75.11%的控股子公司白云山汉方旗下产品。当日关注点交易信息汇总：9月28日主力资金净流出530.89万元，占总成交额6.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900001702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1515","BK0070","BK1606","BK1191","600332","BK0175","BK0028","BK0096","BK0196","00874","BK0188","BK0012","BK0183","BK1521","BK1197","BK0097"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gybys.com.cn","stockEarnings":[{"period":"1week","weight":-0.0376},{"period":"1month","weight":-0.0318},{"period":"3month","weight":-0.1555},{"period":"6month","weight":-0.1912},{"period":"1year","weight":-0.2464},{"period":"ytd","weight":-0.2332}],"compareEarnings":[{"period":"1week","weight":-0.0469},{"period":"1month","weight":-0.0858},{"period":"3month","weight":-0.0813},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.1104},{"period":"ytd","weight":-0.1052}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.009908},{"month":2,"riseRate":0.714286,"avgChangeRate":0.058543},{"month":3,"riseRate":0.586207,"avgChangeRate":0.049537},{"month":4,"riseRate":0.62069,"avgChangeRate":0.081866},{"month":5,"riseRate":0.551724,"avgChangeRate":0.044368},{"month":6,"riseRate":0.482759,"avgChangeRate":0.018954},{"month":7,"riseRate":0.448276,"avgChangeRate":-0.011349},{"month":8,"riseRate":0.37931,"avgChangeRate":-0.040031},{"month":9,"riseRate":0.413793,"avgChangeRate":-0.01093},{"month":10,"riseRate":0.413793,"avgChangeRate":0.002626},{"month":11,"riseRate":0.448276,"avgChangeRate":0.008393},{"month":12,"riseRate":0.535714,"avgChangeRate":0.023642}],"exchange":"SEHK","name":"白云山","nameEN":"BAIYUNSHAN PH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,00874,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}